MOB.ST - Moberg Pharma AB (publ)

Stockholm - Stockholm Real Time Price. Currency in SEK
+0.65 (+2.65%)
At close: 4:43PM CET
Stock chart is not supported by your current browser
Previous Close24.50
Bid24.75 x 0
Ask25.00 x 0
Day's Range24.50 - 25.15
52 Week Range22.50 - 59.25
Avg. Volume39,238
Market Cap480.134M
PE Ratio (TTM)39.30
EPS (TTM)0.64
Earnings DateMay 8, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est39.80
  • PR Newswire11 days ago

    The Nomination Committee's Proposal to the Annual General Meeting 2018

    STOCKHOLM, March 13, 2018 /PRNewswire/ -- Moberg Pharma AB (OMX:MOB) announces that the company's Nomination Committee has decided to present the following proposal to the Annual General Meeting 2018. The Nomination Committee consists of the Chairman Gillis Cullin representing Östersjöstiftelsen and the members Fredrik Persson representing Zimbrine Holding BV, Anders Rodebjer representing Wolco Invest and Thomas Eklund, Chairman of the Board of Directors in the Company. The Nomination Committee proposes that Thomas Eklund is elected as Chairman of the Annual General Meeting of shareholders 2018.

  • PR Newswire24 days ago

    Moberg Pharma Divests Balmex® for $4.25 Million

    STOCKHOLM , Feb. 28, 2018 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) has entered into an agreement with Randob Labs to divest the brand Balmex® for a total consideration of $4.25 million ( 34.6 million ...

  • PR Newswirelast month

    Moberg Pharma AB Year-end Report 2017

    STRONG GROWTH FOR KERASAL NAIL INCREASES EBITDA STOCKHOLM , Feb. 13, 2018 /PRNewswire/ -- PERIOD (FULL YEAR 2017)* Net revenue SEK 439.0 million (334.3) EBITDA SEK 89.4 million (77.9) EBITDA margin 20% ...

  • PR Newswire2 months ago

    Moberg Pharma Receives Favorable Outcome From NAD - Main Competitor to Discontinue Current Marketing

    STOCKHOLM , Jan. 15, 2018 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) have received a positive outcome from the NAD (National Advertising Division) regarding a challenge filed on Fungi-Nail, the largest ...

  • PR Newswire4 months ago

    Moberg Pharma Reorganizes its Commercial Operations

    STOCKHOLM , Nov. 30th, 2017 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) is reorganizing its sales and marketing operations to better reflect the company's increased focus on the North American market and ...